AsOf

Recorded or changed on this day 2026-11-08

2,351–2,400 of 46,541 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,656,000,000 United States dollar
Amgen quarterly operating income: 2,656,000,000 United States dollar, claim clm_C2025A73F657 · ended · superseded by clm_A957F605C563 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 46,936,000,000 United States dollar
Amgen total assets: 46,936,000,000 United States dollar, claim clm_C21B53A4E862 · ended · superseded by clm_4D9D4E243B38 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,526,000,000 United States dollar
Amgen quarterly revenue: 6,526,000,000 United States dollar, claim clm_C2407B4C4D35 · ended · superseded by clm_77995E036FCF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 533,579,206 shares
Amgen shares outstanding: 533,579,206 shares, claim clm_C279B018E45E · ended · superseded by clm_7EB6F1E516E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 760,323,664 shares
Amgen shares outstanding: 760,323,664 shares, claim clm_C311BB3AF4EC · ended · superseded by clm_AC443719191E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 594,183,541 shares
Amgen shares outstanding: 594,183,541 shares, claim clm_C38259D1A5D3 · ended · superseded by clm_AB83B8B5713B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 8,028,000,000 United States dollar
Amgen cash and equivalents: 8,028,000,000 United States dollar, claim clm_C3AA215549F9 · ended · superseded by clm_8E5607E4B59B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,022,000,000 United States dollar
Amgen quarterly operating income: 2,022,000,000 United States dollar, claim clm_C47F1D4F30C5 · ended · superseded by clm_F0CFF35E1C2C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 7,656,000,000 United States dollar
Amgen total equity: 7,656,000,000 United States dollar, claim clm_C48050D45C2E · ended · superseded by clm_E5BB4CC8EC5C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 28,190,000,000 United States dollar
Amgen revenue: 28,190,000,000 United States dollar, claim clm_C49E0455CA9B · ended · superseded by clm_F31DA2CA4F3F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,179,000,000 United States dollar
Amgen quarterly operating income: 1,179,000,000 United States dollar, claim clm_C4A7A3DD6E59 · ended · superseded by clm_A00D04DA0A77 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 27,484,000,000 United States dollar
Amgen total equity: 27,484,000,000 United States dollar, claim clm_C5ED4B615A7E · ended · superseded by clm_92CB2B598E88 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 6,552,000,000 United States dollar
Amgen net income: 6,552,000,000 United States dollar, claim clm_C644E157DE79 · ended · superseded by clm_566AA4B9BFA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 51,640,000,000 United States dollar
Amgen total assets: 51,640,000,000 United States dollar, claim clm_C67140F0772C · ended · superseded by clm_39B4E0673406 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 25,241,000,000 United States dollar
Amgen total equity: 25,241,000,000 United States dollar, claim clm_C6D997322E62 · ended · superseded by clm_3940E74F06F0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 15,582,000,000 United States dollar
Amgen revenue: 15,582,000,000 United States dollar, claim clm_C7A9E438A984 · ended · superseded by clm_EC47C2B5A921 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 464,000,000 United States dollar
Amgen quarterly net income: 464,000,000 United States dollar, claim clm_C8266FA25464 · ended · superseded by clm_79D0F6379AE0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 755,007,290 shares
Amgen shares outstanding: 755,007,290 shares, claim clm_C9B23C443A68 · ended · superseded by clm_37781152ABE8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 89,367,000,000 United States dollar
Amgen total assets: 89,367,000,000 United States dollar, claim clm_C9D442A37C8E · ended · superseded by clm_A58542830DFC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 43,486,000,000 United States dollar
Amgen total assets: 43,486,000,000 United States dollar, claim clm_CA6A5441CDCF · ended · superseded by clm_6C5A646418EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,479,000,000 United States dollar
Amgen quarterly operating income: 1,479,000,000 United States dollar, claim clm_CAB7E6C967C3 · ended · superseded by clm_087D410B4794 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,402,000,000 United States dollar
Amgen quarterly operating income: 2,402,000,000 United States dollar, claim clm_CB3F23126391 · ended · superseded by clm_D18BB69DF47F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 22,096,000,000 United States dollar
Amgen total equity: 22,096,000,000 United States dollar, claim clm_CC7EBB14F5AA · ended · superseded by clm_2F8840B9A878 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,206,000,000 United States dollar
Amgen quarterly revenue: 6,206,000,000 United States dollar, claim clm_CCB0903B5673 · ended · superseded by clm_A9C5A1ACE96F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,323,000,000 United States dollar
Amgen quarterly operating income: 2,323,000,000 United States dollar, claim clm_CCCD3C3FB13D · ended · superseded by clm_03D15401052C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 828,000,000 United States dollar
Amgen quarterly operating income: 828,000,000 United States dollar, claim clm_CDC5FFCBE990 · ended · superseded by clm_971916A525E3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 622,278,034 shares
Amgen shares outstanding: 622,278,034 shares, claim clm_CE1D1BBB65EB · ended · superseded by clm_226B9B63D1EC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 8,388,000,000 United States dollar
Amgen quarterly revenue: 8,388,000,000 United States dollar, claim clm_CE8800B79AA0 · ended · superseded by clm_BF9D0F8819AD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 69,534,000,000 United States dollar
Amgen total assets: 69,534,000,000 United States dollar, claim clm_CF482D232326 · ended · superseded by clm_7D37893DF373 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,491,000,000 United States dollar
Amgen total equity: 19,491,000,000 United States dollar, claim clm_D045AE9FFC56 · ended · superseded by clm_D15F50A325E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,586,000,000 United States dollar
Amgen total assets: 90,586,000,000 United States dollar, claim clm_D061D89A7312 · ended · superseded by clm_109E7FAE5B37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 59,294,000,000 United States dollar
Amgen total assets: 59,294,000,000 United States dollar, claim clm_D091B9D69D1A · ended · superseded by clm_2130B296B9EF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 20,594,000,000 United States dollar
Amgen total equity: 20,594,000,000 United States dollar, claim clm_D15F50A325E7 · ended · superseded by clm_F959576F5D57 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,380,000,000 United States dollar
Amgen quarterly operating income: 2,380,000,000 United States dollar, claim clm_D18BB69DF47F · ended · superseded by clm_29CEBD7716C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 876,544,275 shares
Amgen shares outstanding: 876,544,275 shares, claim clm_D1EFB8E701BD · ended · superseded by clm_814F8DBF99DF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 5,867,000,000 United States dollar
Amgen operating income: 5,867,000,000 United States dollar, claim clm_D1F7CCF21F2B · ended · superseded by clm_7FEB7D7DF8E7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 7,358,000,000 United States dollar
Amgen cash and equivalents: 7,358,000,000 United States dollar, claim clm_D20943685A4B · ended · superseded by clm_E548AD354AFD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 7,897,000,000 United States dollar
Amgen operating income: 7,897,000,000 United States dollar, claim clm_D213C7365716 · ended · superseded by clm_14D79C128253 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 22,858,000,000 United States dollar
Amgen total equity: 22,858,000,000 United States dollar, claim clm_D33321EF3A62 · ended · superseded by clm_DBA659E53482 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 75,471,000,000 United States dollar
Amgen total assets: 75,471,000,000 United States dollar, claim clm_D40F2EB93762 · ended · superseded by clm_37FDCE0641B8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 4,477,000,000 United States dollar
Amgen quarterly revenue: 4,477,000,000 United States dollar, claim clm_D4DC1453EF41 · ended · superseded by clm_5BA2730341DC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 11,688,000,000 United States dollar
Amgen total equity: 11,688,000,000 United States dollar, claim clm_D4E836330B03 · ended · superseded by clm_1845D943407A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 22,849,000,000 United States dollar
Amgen revenue: 22,849,000,000 United States dollar, claim clm_D4EEBB71EC7D · ended · superseded by clm_340FB654E4B9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,017,000,000 United States dollar
Amgen quarterly net income: 2,017,000,000 United States dollar, claim clm_D60223B7773B · ended · superseded by clm_7D03D58A08B9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,875,000,000 United States dollar
Amgen quarterly revenue: 3,875,000,000 United States dollar, claim clm_D6A6F66C922D · ended · superseded by clm_E30E52778B73 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 64,637,000,000 United States dollar
Amgen total assets: 64,637,000,000 United States dollar, claim clm_D6F0A4676DE8 · ended · superseded by clm_EA5FD7A5E873 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,125,000,000 United States dollar
Amgen quarterly net income: 1,125,000,000 United States dollar, claim clm_D713C582BE0E · ended · superseded by clm_6E8F27E2EA0D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 588,247,399 shares
Amgen shares outstanding: 588,247,399 shares, claim clm_D739E45E5467 · ended · superseded by clm_1A0716269BBF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 4,352,000,000 United States dollar
Amgen cash and equivalents: 4,352,000,000 United States dollar, claim clm_DA248B5305A9 · ended · superseded by clm_10CF13C1B54A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,823,000,000 United States dollar
Amgen cash and equivalents: 5,823,000,000 United States dollar, claim clm_DA97E5CF2AF5 · ended · superseded by clm_05AF32DE89A0 · 1 source (1 primary) · conf 0.95

What the statuses mean